Cardlytics (CDLX) Return on Equity (2017 - 2026)

Cardlytics has reported Return on Equity for 10 years, with the latest figure at 0.15% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity rose 18.0% year-over-year to 0.15%; the trailing twelve-month figure through Mar 2026 stood at 0.15% (up 18.0% YoY), and the FY2025 full-year result was 0.03%, down 1.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.15%, down from 0.17% in the prior quarter.
• The five-year high for Return on Equity was 0.17% in Q4 2025, with the low at 0.04% in Q3 2025.
• Historically, Return on Equity has averaged 0.0% across 5 years, with a median of 0.01% in 2022.
• Annual changes were most pronounced in 2023 — Return on Equity fell 2 bps — and 2025, when it advanced 19 bps.
• Cardlytics' Return on Equity stood at 0.01% in 2022, then soared by 36 bps to 0.01% in 2023, then sank by 262 bps to 0.03% in 2024, then jumped by 713 bps to 0.17% in 2025, then decreased by 7 bps to 0.15% in 2026.
• The last three Return on Equity figures came in at 0.15% (Q1 2026), 0.17% (Q4 2025), and 0.04% (Q3 2025), per Business Quant data.